The Common Vein

• Chronic Eosinophilic Pneumonia (CEP) is an
• inflammatory lung disease

Chronic Eosinophilic Pneumonia Affects the Alveoli and Alveolar Septal Interstitium 

• 

  Title	Details
  Definition	Chronic eosinophilic pneumonia is an idiopathic eosinophilic lung disease. Characterized by subacute or chronic respiratory and systemic symptoms. Associated with blood and/or BAL eosinophilia. Shows peripheral, often upper-lobe predominant pulmonary infiltrates on imaging. Diagnosed after exclusion of secondary causes of eosinophilic lung disease.
  Cause	Etiology usually idiopathic after appropriate exclusion work-up. Strong association with asthma and atopy in a substantial proportion of patients. Represents a Th2-skewed eosinophilic immune response within the lung. Occasional reports after radiotherapy or environmental exposures, but no single consistent trigger.
  Pathophysiology	Th2-biased immune response with increased IL-5 and other eosinophil-active cytokines. Recruitment and accumulation of eosinophils in alveolar spaces and interstitium. Eosinophils release cytotoxic granule proteins, cytokines, and reactive oxygen species. Results in alveolar injury and an organizing pneumonia-like inflammatory pattern. Recurrent eosinophilic inflammation may contribute to airway remodeling over time.
  Structural result	Peripheral, non-segmental ground-glass opacities and consolidations on CT. Often upper-lobe predominant and subpleural in distribution. Classic but inconstant “photographic negative of pulmonary edema” pattern on chest radiograph. Histology shows eosinophil-rich alveolar and interstitial infiltrates. Frequently associated with foci of organizing pneumonia.
  Clinical features	Subacute onset over weeks to months rather than hours or days. Progressive dyspnea and cough are the dominant respiratory symptoms. Systemic features such as weight loss, fatigue, night sweats, and low-grade fever are common. Often occurs in non-smoking, middle-aged women with a personal history of asthma or atopy. Hypoxemia is usually mild to moderate and frank respiratory failure is uncommon at presentation. Extrapulmonary organ involvement is absent and should prompt consideration of EGPA or HES if present.
  Imaging	Chest radiograph shows bilateral or unilateral peripheral airspace opacities. Opacities are often non-segmental and upper-lobe predominant. Reverse bat-wing or “photographic negative of pulmonary edema” pattern is classic but not universal. CT demonstrates peripheral and subpleural ground-glass opacities and consolidations. Air bronchograms within areas of consolidation are common. Opacities may be migratory on serial imaging. Pleural effusion is uncommon and should prompt evaluation for alternative or co-existing processes.
  Labs / Physiology	Peripheral blood eosinophilia is typical and often exceeds 1,000 cells/mm³. Bronchoalveolar lavage frequently shows eosinophilia of 40% or higher when performed. Inflammatory markers such as ESR and CRP are usually elevated. Total IgE is often increased, especially in atopic individuals. Pulmonary function testing may show restrictive, obstructive, or mixed ventilatory defects. Diffusing capacity for carbon monoxide (DLCO) is frequently reduced. Arterial blood gases typically reveal mild to moderate hypoxemia.
  Treatment	Systemic corticosteroids are the first-line therapy. Typical induction regimen uses oral prednisone at approximately 0.5–1 mg/kg/day. Clinical and radiologic response is rapid, often within days of starting steroids. Steroid dose is tapered gradually over months to reduce relapse risk. Many patients require long-term low-dose oral or inhaled corticosteroids. Biologic therapy targeting IL-5 or related pathways may be considered in steroid-dependent or refractory disease. Long-term management includes strategies to mitigate corticosteroid toxicity such as bone and metabolic protection.
  Prognosis	Short-term prognosis is excellent with appropriate steroid therapy. Most patients experience rapid and near-complete symptomatic and radiologic resolution of each episode. Relapses occur in approximately half of patients, often during or after steroid tapering. Despite relapses, episodes remain highly responsive to corticosteroids. A subset of patients develop persistent airflow limitation and chronic functional impairment, especially with coexisting severe asthma or frequent relapses. Overall mortality is low and long-term outcome is influenced more by steroid toxicity and comorbidities than by CEP itself.

Chronic Eosinophilic Pneumonia vs Acute Eosinophilic Pneumonia vs COP vs HP

Feature	Chronic Eosinophilic Pneumonia (CEP)	Acute Eosinophilic Pneumonia (AEP)	Cryptogenic Organizing Pneumonia (COP)	Hypersensitivity Pneumonitis (HP)
Tempo / Onset	Subacute to chronic onset. Symptoms evolve over weeks to months.	Acute onset. Progresses over hours to a few days. Frequently presents as acute respiratory failure.	Subacute onset. Symptoms over weeks to a few months.	Acute, subacute, or chronic depending on exposure pattern. Acute: hours to days after heavy exposure. Subacute and chronic: insidious over weeks to months.
Typical Patient Profile	Often middle-aged, frequently female. Non-smoker in many series. Asthma or atopy common.	Previously healthy young adult. Recent new smoking, vaping, or inhalational exposure often present.	Middle-aged adult. No specific sex predilection. May follow viral illness or drug exposure, but often idiopathic.	Patient with repeated antigen exposure. Examples: birds, mold, hot-tub, farming, humidifiers, occupational antigens.
Clinical Features	Dyspnea and non-productive cough. Constitutional symptoms: weight loss, fatigue, night sweats, low-grade fever. Asthma history frequent. Respiratory failure uncommon at presentation.	Acute febrile illness with cough and dyspnea. Pleuritic chest pain possible. Hypoxemic respiratory failure frequent. May require ICU and mechanical ventilation.	Dry cough and exertional dyspnea. Low-grade fever and malaise common. Pleuritic chest pain can occur. No peripheral eosinophilia in most cases.	Cough, dyspnea, and fatigue. Symptoms often worse at work or at home depending on exposure site. Acute episodes may have fever and flu-like symptoms.
Blood / BAL Profile	Peripheral blood eosinophilia is typical. BAL eosinophilia often ≥40% when sampled. IgE often elevated; atopy common.	Early blood eosinophilia may be absent or mild. BAL shows marked eosinophilia. Neutrophils may also be increased early.	Peripheral blood eosinophilia usually absent. BAL often shows lymphocytosis > eosinophilia.	Peripheral eosinophilia is not a defining feature. BAL typically shows lymphocytosis with increased CD8 cells. CD4/CD8 ratio often reduced in classic HP.
Imaging Pattern	Peripheral, non-segmental GGO and consolidation. Often upper-lobe and subpleural predominant. Reverse bat-wing / “photographic negative” of pulmonary edema is classic but inconstant. Opacities may be migratory on follow-up imaging.	Diffuse or patchy bilateral GGO and consolidation. Often mid- to lower-zone predominant. Interlobular septal thickening may be present. Pleural effusions are common.	Patchy, often bilateral peripheral or peribronchovascular consolidation. Atoll sign (reverse halo) may be present. Nodular or band-like opacities along bronchovascular bundles. Distribution variable, not characteristically eosinophilic.	Acute HP: diffuse or mid-zone predominant GGO and centrilobular nodules. Subacute HP: ill-defined centrilobular nodules, mosaic attenuation, and air-trapping. Chronic HP: fibrosis with traction bronchiectasis, lobular air-trapping, and heterogeneous attenuation.
Pathology (Conceptual)	Alveolar and interstitial eosinophil-rich infiltrates. Often shows associated organizing pneumonia. No necrotizing vasculitis.	Diffuse eosinophilic infiltration of lung parenchyma. Alveolar damage and edema. Can resemble diffuse alveolar damage with eosinophils.	Intraluminal fibroblastic plugs (Masson bodies) in alveolar ducts, alveoli, and bronchioles. Preserved lung architecture. Minimal eosinophils relative to CEP or AEP.	Cellular bronchiolitis with peribronchiolar inflammation. Interstitial lymphoplasmacytic infiltrates. Non-caseating poorly formed granulomas and giant cells.
Treatment & Course	Systemic corticosteroids are first-line. Rapid and dramatic clinical and radiologic response. Relapses are common, especially during taper or after cessation. Some patients require long-term low-dose steroids or steroid-sparing strategies.	Systemic corticosteroids are mainstay once AEP is recognized. Often requires initial supportive care including oxygen and sometimes mechanical ventilation. Long-term relapses are uncommon once the trigger is removed.	Systemic corticosteroids are standard therapy. Good response in most patients. Relapses can occur, especially if taper is rapid.	Cornerstone of management is antigen avoidance or exposure reduction. Systemic or inhaled corticosteroids often used for acute and subacute disease. Chronic fibrotic HP may progress despite treatment.
Key Imaging / Clinical Discriminators	Subacute symptoms in an asthmatic or atopic patient. Peripheral, often upper-lobe predominant opacities. Blood and BAL eosinophilia. “Photographic negative” edema pattern strongly suggests CEP when present.	Acute severe illness with hypoxemia. Diffuse bilateral infiltrates and pleural effusions. BAL eosinophilia with minimal early blood eosinophilia. Often history of new smoking, vaping, or inhalational exposure.	Subacute, non-eosinophilic pneumonia. Patchy peripheral or peribronchovascular consolidations and atoll sign. No marked eosinophilia in blood or BAL.	Clear link to recurrent antigen exposure. Centrilobular nodules, mosaic attenuation, and air-trapping on CT. Lymphocytic BAL with CD8 predominance. Improves with avoidance of the offending antigen.

 

DDX of Upper-Lobe Crescentic Mixed Opacities (Index: Chronic Eosinophilic Pneumonia)

Diagnosis	Details / Why It’s in the DDX & How to Distinguish
Chronic Eosinophilic Pneumonia (CEP)	Subacute to chronic symptoms: dyspnea, cough, weight loss, low-grade fever. Peripheral, often upper-lobe–predominant ground-glass opacities and consolidation. Crescentic or band-like subpleural opacities; can approximate a reverse bat-wing pattern. Opacities may be migratory on serial imaging. Peripheral blood and/or BAL eosinophilia is typical. Asthma / atopy common; extrapulmonary organ involvement absent. Dramatic response to systemic corticosteroids.
Cryptogenic Organizing Pneumonia (COP)	Subacute presentation with cough, dyspnea, low-grade fever, malaise. Patchy peripheral or peribronchovascular consolidations; sometimes crescentic or band-like. Reverse halo (atoll) sign can be present but is not required. Blood eosinophilia typically absent; BAL often lymphocyte-predominant. No strong association with asthma or atopy. Good response to steroids but not classically eosinophilic on labs or BAL.
Hypersensitivity Pneumonitis (HP) – Subacute / Chronic	History of repeated antigen exposure (birds, molds, farming, hot-tub, occupational antigens). Imaging may show upper-lobe or mid-zone–predominant ground-glass and patchy opacities. Key CT pattern: centrilobular nodules, mosaic attenuation, and lobular air trapping. Peripheral crescentic opacities possible but small-airways signs (mosaic / air trapping) are more characteristic. BAL: lymphocytosis with CD8 predominance; eosinophilia is not a dominant feature. Improvement with antigen avoidance supports HP over CEP.
Eosinophilic Granulomatosis with Polyangiitis (EGPA)	Asthma, eosinophilia, and systemic small-vessel vasculitis (neuropathy, purpura, renal disease, GI, etc.). Imaging may show peripheral and upper-lobe-predominant consolidations resembling CEP. Opacities can be migratory and mixed ground-glass / consolidation. Extrapulmonary organ involvement and vasculitic manifestations are key discriminators. ANCA may be positive but is not obligatory. Think EGPA if you see CEP-like lung plus clear multisystem vasculitis.
Acute Eosinophilic Pneumonia (AEP)	Acute febrile illness with rapid progression to hypoxemic respiratory failure. Diffuse or widespread bilateral ground-glass opacities and consolidation; not typically purely crescentic. Pleural effusions are common; distribution often mid- to lower-zone predominant. Early blood eosinophilia may be absent; BAL eosinophilia is characteristic. History of new smoking, vaping, or inhalational exposure is common. Consider AEP when the clinical course is hyper-acute and severe rather than subacute.
Drug-Induced Eosinophilic / Organizing Pneumonia	History of recent or ongoing exposure to a culprit drug (e.g. NSAIDs, certain antibiotics, daptomycin, checkpoint inhibitors). Imaging can show peripheral crescentic consolidations or mixed GGO and consolidation. May mimic CEP, AEP, or COP patterns on CT. Blood and BAL eosinophilia may be present in eosinophilic variants. Improvement after drug withdrawal (± steroids) supports drug-induced disease.
Radiation Pneumonitis	History of thoracic or breast/chest wall radiotherapy. Crescentic or band-like subpleural consolidation in the irradiated lung, often upper lobe for breast RT. Opacities strictly conform to the radiation field rather than a purely eosinophilic pattern. Symptoms appear weeks to a few months post-radiation.
Sarcoidosis (Atypical Parenchymal Pattern)	Upper-lobe–predominant disease is typical. Perilymphatic nodules along bronchovascular bundles, septa, and fissures are classic. Patchy consolidation or band-like opacities may occasionally mimic CEP. Hilar and mediastinal lymphadenopathy common. No blood or BAL eosinophilia as a defining feature.
Pulmonary Infarction (Less Common Mimic)	Acute pleuritic chest pain and dyspnea. Subpleural wedge-shaped or crescentic opacity; often lower-lobe predominant but can involve upper lobes. Associated CT pulmonary angiography shows filling defects in pulmonary arteries. Lack of eosinophilia and typical vascular risk factors help distinguish from CEP.

 

 

Peripheral Infiltrates 

Links and References

Crowe M et al Therapeutics and Clinical Risk Management Volume 15:397-403 March 2019  Source Research Gate

• • TCV
    • • Eosinophilic lung disease
        • • Systemic
            • Eosinophilic granulomatosis with polyangiitis (EGPA) aka Churg Strauss Disease
            • Hyper-eosinophilic syndrome
          • Lung limited diseases
            • Acute eosinophilic pneumonia (AEP),
            • Chronic eosinophilic pneumonia (CEP), and
            • Loeffler syndrome